Stocks in news: Numerex Corp. (NASDAQ:NMRX), StemCells Inc. (NASDAQ:STEM), Arena Pharmaceuticals (NASDAQ:ARNA), Identiv (NASDAQ:INVE), Vantage Drilling Company (NYSEMKT:VTG)


Numerex Corp (Nasdaq:NMRX), announced financial results for its fourth quarter and full year ended December 31, 2014. Sales and marketing expenses were $2.8 million compared to $2.6 million. The increase was due to our acquisition of Omnilink and the addition of sales and marketing personnel to drive and support growth. On Thursday shares of Numerex Corp. (NASDAQ:NMRX) closed at $11.20. Company’s sales growth for last 5 years was 1.50% and EPS growth for next 5 years is recorded as 15.00%.

StemCells, Inc. (Nasdaq:STEM) announced that it will release financial results for the fourth quarter and full year ended December 31, 2014, after the market close on Monday, March 16. StemCells Inc. (NASDAQ:STEM) in last trading activity moved up 5.08% to close at $1.24. Company weekly performance is -3.88% while its quarterly performance stands at 19.23%. StemCells Inc. (NASDAQ:STEM) is -48.97% away from its 52 week high.

On March 2, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the fourth quarter and full year ended December 31, 2014. Revenues totaled $37.0 million, including $16.0 million in net product sales of BELVIQ, of which $14.2 million represented 31.5% of Eisai’s net product sales and $1.8 million related to redemptions of the 15-day free voucher and product samples. On Thursday shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $4.63. Company’s sales growth for last 5 years was 28.90%.

Identiv Inc. (NASDAQ:INVE) on Thursday reported a loss of $6.2 million in its fourth quarter. For the year, the company reported that its loss narrowed to $17.8 million, or $2.06 per share. Revenue was reported as $81.2 million. Identiv, Inc. (NASDAQ:INVE) has 4.10% insider ownership while its institutional ownership stands at 28.80%. In last trading activity company’s stock closed at $10.63.

Research analysts at RBC Capital cut their price objective on shares of Vantage Drilling Company (NYSEMKT:VTG) from $0.75 to $0.50 in a report released on Monday. The firm currently has a “sector perform” rating on the stock. RBC Capital’s price objective indicates a potential upside of 42.86% from the stock’s previous close. On last trading day Vantage Drilling Company (NYSEMKT:VTG) moved down -1.81% to close at $0.31. Its volatility for the week is 8.29% while volatility for the month is 9.49%. VTG’s sales growth for past 5 years was 282.00% and its EPS growth for past 5 years was 19.10%. Vantage Drilling Company (NYSEMKT:VTG) monthly performance is -45.91%.


Leave a Reply

Your email address will not be published. Required fields are marked *